Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 100,000 shares at $35.22 ($3.5M) on 2025-01-31, disclosed to the SEC on 2025-02-04.
Scheduled sale ($3.5M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |